Target intelligence / Profile preview

Histone H2B type 3-B (H2BC26)

Target
H2BC26
Molecular classification
Histone, Core histone protein, Nucleosome component
01

Overview

Histone H2B type 3-B (H2BC26) is a replication-dependent nuclear protein that forms one of the four core histones responsible for the nucleosome structure in eukaryotic cells. The nucleosome consists of DNA wrapped around an octamer of histones (two molecules each of H2A, H2B, H3, and H4), providing compaction and organization to chromatin. H2BC26, specifically, is an isoform of H2B, and contributes to core chromatin functions including transcription regulation, DNA replication, DNA repair, and maintenance of genome stability through post-translational modifications such as acetylation, phosphorylation, and ubiquitination. While H2BC26 is fundamentally structural and not typically considered a druggable therapeutic target, its altered expression or modification has been associated with certain diseases such as hematologic cancer. There is no evidence for small-molecule drugs or biological agents directly targeting this specific isoform, and interfering with core histones generally poses significant safety concerns due to their essential role in cell viability.

Other names
H2B clustered histone 26H2BC26H2BU1HIST3H2BBH2B type 12H2B.U histone 1H2Bbhistone cluster 3 H2B family member bhistone cluster 3H2bb
02

Biological functions

Chromatin structure organizationDNA packagingRegulation of transcriptionDNA replicationDNA repairRegulation of chromatin accessibility
03

Disease associations

Cancer (e.g., hematologic cancer)Other (altered regulation in chromatin-related pathologies inferred from core histone function)
04

Safety considerations

Targeting core histones is likely to lead to broad cytotoxicity, as they are essential for chromosome structure and basic cell viability

Beyond the preview

Go deeper on Histone H2B type 3-B (H2BC26).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Histone H2B type 3-B (H2BC26).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call